Cargando…

异基因造血干细胞移植治疗原发性血小板增多症转化的急性髓系白血病三例报告并文献复习

OBJECTIVE: To investigate the characteristics of the essential thrombocythemia (ET) cases transformed to the acute myeloid leukemia (AML) and the role of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the treatment of this disease. METHODS: The clinical and laboratory characterist...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364958/
https://www.ncbi.nlm.nih.gov/pubmed/29166742
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.10.011
_version_ 1783559946739122176
collection PubMed
description OBJECTIVE: To investigate the characteristics of the essential thrombocythemia (ET) cases transformed to the acute myeloid leukemia (AML) and the role of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the treatment of this disease. METHODS: The clinical and laboratory characteristics of 3 ET cases before and after transformation and after allo-HSCT were retrospectively analyzed, meanwhile the related literatures were reviewed and discussed. RESULTS: Case 1 was a male patient of 44 years old, whose PLT was 500×10(9)/L when firstly diagnosed ET. After 3 years the disease progressed into myelodysplastic syndrome (MDS) while WT1 expression increased from 77 (first visit) to 13 171 copies/10 000 ABL copies, at the same time chromosome changed dramatically. During the period of decitabine treatment the disease processed into AML. Case 2 was a male of 58 years old whose PLT was 2 100×10(9)/L when firstly diagnosed ET. The disease progressed to AML after 9 years, whose WT1 expression increased from 130 (first visit) to 3 222 copies/10 000 ABL copies, and he relapsed shortly after intensive chemotherapy. Case 3 was a male of 60 years old whose PLT was 900×10(9)/L when firstly diagnosed ET. The disease progressed to AML after 5 years, whose WT1 increased from 56 (first visit) to3 696 copies/10 000 ABL copies. Moreover leukemia spread to central nervous system (CNS) during chemotherapy. Before allo-HSCT, cases 1 did not achieve remission; case 2 relapsed after a short time of remission and case 3 transferred to CNS leukemia. All of the 3 cases underwent allo-HSCT successfully, and they all achieved completely remission, whose chromosome and gene mutation recovered negative. At the same time, CNS leukemia of case 3 disappeared. The median WT1 decreased to 50 copies/10 000 ABL copies. There was no severe complication during the median time of 5 months after allo-HSCT. CONCLUSION: The patients transformed to AML had poor prognosis, allo-HSCT was the only method that can cure the disease now.
format Online
Article
Text
id pubmed-7364958
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73649582020-07-16 异基因造血干细胞移植治疗原发性血小板增多症转化的急性髓系白血病三例报告并文献复习 Zhonghua Xue Ye Xue Za Zhi 论著 OBJECTIVE: To investigate the characteristics of the essential thrombocythemia (ET) cases transformed to the acute myeloid leukemia (AML) and the role of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the treatment of this disease. METHODS: The clinical and laboratory characteristics of 3 ET cases before and after transformation and after allo-HSCT were retrospectively analyzed, meanwhile the related literatures were reviewed and discussed. RESULTS: Case 1 was a male patient of 44 years old, whose PLT was 500×10(9)/L when firstly diagnosed ET. After 3 years the disease progressed into myelodysplastic syndrome (MDS) while WT1 expression increased from 77 (first visit) to 13 171 copies/10 000 ABL copies, at the same time chromosome changed dramatically. During the period of decitabine treatment the disease processed into AML. Case 2 was a male of 58 years old whose PLT was 2 100×10(9)/L when firstly diagnosed ET. The disease progressed to AML after 9 years, whose WT1 expression increased from 130 (first visit) to 3 222 copies/10 000 ABL copies, and he relapsed shortly after intensive chemotherapy. Case 3 was a male of 60 years old whose PLT was 900×10(9)/L when firstly diagnosed ET. The disease progressed to AML after 5 years, whose WT1 increased from 56 (first visit) to3 696 copies/10 000 ABL copies. Moreover leukemia spread to central nervous system (CNS) during chemotherapy. Before allo-HSCT, cases 1 did not achieve remission; case 2 relapsed after a short time of remission and case 3 transferred to CNS leukemia. All of the 3 cases underwent allo-HSCT successfully, and they all achieved completely remission, whose chromosome and gene mutation recovered negative. At the same time, CNS leukemia of case 3 disappeared. The median WT1 decreased to 50 copies/10 000 ABL copies. There was no severe complication during the median time of 5 months after allo-HSCT. CONCLUSION: The patients transformed to AML had poor prognosis, allo-HSCT was the only method that can cure the disease now. Editorial office of Chinese Journal of Hematology 2017-10 /pmc/articles/PMC7364958/ /pubmed/29166742 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.10.011 Text en 2017年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 论著
异基因造血干细胞移植治疗原发性血小板增多症转化的急性髓系白血病三例报告并文献复习
title 异基因造血干细胞移植治疗原发性血小板增多症转化的急性髓系白血病三例报告并文献复习
title_full 异基因造血干细胞移植治疗原发性血小板增多症转化的急性髓系白血病三例报告并文献复习
title_fullStr 异基因造血干细胞移植治疗原发性血小板增多症转化的急性髓系白血病三例报告并文献复习
title_full_unstemmed 异基因造血干细胞移植治疗原发性血小板增多症转化的急性髓系白血病三例报告并文献复习
title_short 异基因造血干细胞移植治疗原发性血小板增多症转化的急性髓系白血病三例报告并文献复习
title_sort 异基因造血干细胞移植治疗原发性血小板增多症转化的急性髓系白血病三例报告并文献复习
topic 论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364958/
https://www.ncbi.nlm.nih.gov/pubmed/29166742
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.10.011
work_keys_str_mv AT yìjīyīnzàoxuègànxìbāoyízhízhìliáoyuánfāxìngxuèxiǎobǎnzēngduōzhèngzhuǎnhuàdejíxìngsuǐxìbáixuèbìngsānlìbàogàobìngwénxiànfùxí
AT yìjīyīnzàoxuègànxìbāoyízhízhìliáoyuánfāxìngxuèxiǎobǎnzēngduōzhèngzhuǎnhuàdejíxìngsuǐxìbáixuèbìngsānlìbàogàobìngwénxiànfùxí
AT yìjīyīnzàoxuègànxìbāoyízhízhìliáoyuánfāxìngxuèxiǎobǎnzēngduōzhèngzhuǎnhuàdejíxìngsuǐxìbáixuèbìngsānlìbàogàobìngwénxiànfùxí
AT yìjīyīnzàoxuègànxìbāoyízhízhìliáoyuánfāxìngxuèxiǎobǎnzēngduōzhèngzhuǎnhuàdejíxìngsuǐxìbáixuèbìngsānlìbàogàobìngwénxiànfùxí
AT yìjīyīnzàoxuègànxìbāoyízhízhìliáoyuánfāxìngxuèxiǎobǎnzēngduōzhèngzhuǎnhuàdejíxìngsuǐxìbáixuèbìngsānlìbàogàobìngwénxiànfùxí
AT yìjīyīnzàoxuègànxìbāoyízhízhìliáoyuánfāxìngxuèxiǎobǎnzēngduōzhèngzhuǎnhuàdejíxìngsuǐxìbáixuèbìngsānlìbàogàobìngwénxiànfùxí